Varubi 166.5 mg in 92.5 mL Injection
RxNorm 1986889
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1986889 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Varubi 166.5 mg in 92.5 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
92.5 mL rolapitant 1.8 mg/ML Injection [Varubi]
(Atom ID: 9698399)
SY
Synonym (SY):
92.5 mL Varubi 1.8 mg/ML Injection
(Atom ID: 9698401)
SY
Synonym (SY):
Varubi 166.5 mg (equivalent to rolapitant HCl 185 mg) per 92.5 mL Injection
(Atom ID: 9698408)
PSN
Prescribable Name (PSN):
Varubi 166.5 mg in 92.5 mL Injection
(Atom ID: 9698400)
SY
Synonym (SY):
Varubi 166.5 mg per 92.5 mL Injection
(Atom ID: 9698402)
Patient Education
Rolapitant Injection
Rolapitant injection is used along with other medications to prevent nausea and vomiting that may occur several days after receiving certain chemotherapy medications. Rolapitant is in a class of medications called antiemetics. It works by blocking the action of neurokinin and substance P, natural substances in the brain that cause nausea and vomiting.
[Learn More]
* Please review the disclaimer below.